-
1 Comment
Bubs Australia Limited is currently in a long term downtrend where the price is trading 14.2% below its 200 day moving average.
From a valuation standpoint, the stock is 10.2% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 6.1.
Bubs Australia Limited's total revenue sank by 32.5% to $18M since the same quarter in the previous year.
Its net income has dropped by 70.6% to $-13M since the same quarter in the previous year.
Finally, its free cash flow grew by 1.8% to $-8M since the same quarter in the previous year.
Based on the above factors, Bubs Australia Limited gets an overall score of 2/5.
ISIN | AU000000BUB7 |
---|---|
Industry | Packaged Foods |
Sector | Consumer Defensive |
Exchange | AU |
CurrencyCode | AUD |
Market Cap | 107M |
---|---|
PE Ratio | None |
Target Price | 0.1725 |
Beta | 0.29 |
Dividend Yield | None |
Bubs Australia Limited, together with its subsidiaries, engages in the manufacture and sale of various infant nutrition and wellbeing products in Australia, China, the United States, and internationally. The company offers organic baby food, goat milk infant formula, adult goat milk powder, cow's milk and fresh dairy products, as well as organic snacks, plant based baby food pouches, and cereals and porridges. It also provides canning services for nutritional dairy products; and holds IP and trademarks. The company was incorporated in 1993 and is based in Dandenong South, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BUB.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025